FMP
Dec 13, 2024 5:00 AM - Gordon Thompson
Image credit: Google Images
Organigram Holdings Inc. (NASDAQ: OGI, TSX: OGI) is a key player in the cannabis industry, known for producing high-quality cannabis products. The company is set to release its fourth quarter and fiscal 2024 earnings on December 18, 2024. This release will be followed by a conference call to discuss the results, providing insights into the company's financial health.
Wall Street anticipates OGI's earnings per share (EPS) to be -$0.03, with projected revenue of $43.8 million. Despite these expectations, OGI's current financial metrics reveal challenges. The company has a negative price-to-earnings (P/E) ratio of -3.06, indicating ongoing negative earnings. This suggests that the company is not currently profitable.
OGI's price-to-sales ratio is approximately 1.45, showing that investors are willing to pay $1.45 for every dollar of sales. This ratio is a measure of how much investors value the company's sales. Additionally, the enterprise value to sales ratio is about 0.96, which may suggest a relatively low valuation compared to its sales.
The company's enterprise value to operating cash flow ratio is around -7.61, reflecting negative operating cash flow. This indicates that OGI is not generating positive cash flow from its operations. Furthermore, the earnings yield is approximately -32.71%, reinforcing the negative earnings situation.
Despite these challenges, OGI maintains a strong liquidity position with a current ratio of approximately 4.29. This means the company has more than enough current assets to cover its current liabilities. Additionally, OGI has a very low debt-to-equity ratio of about 0.00034, indicating minimal reliance on debt financing.
Sep 10, 2024 11:33 AM - Parth Sanghvi
When it comes to downloading historical stock data, Yahoo Finance has been a popular choice for many. However, for those looking for more comprehensive, accurate, and flexible options, Financial Modeling Prep (FMP) offers a suite of powerful tools and services that stand out as superior alternatives...
Nov 8, 2024 10:30 AM - Sanzhi Kobzhan
When it comes to investing in stocks, one of the key decisions an investor must make involves determining the intrinsic value of a company's shares. Equity valuation isn't just about numbers, it's an art mixed with science, aiming to predict future performance based on current and historical data. H...
Nov 22, 2024 10:08 AM - Parth Sanghvi
Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...